Home/Filings/4/0001209191-09-046204
4//SEC Filing

Elizondo David R 4

Accession 0001209191-09-046204

CIK 0000824068other

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 5:11 PM ET

Size

14.9 KB

Accession

0001209191-09-046204

Insider Transaction Report

Form 4
Period: 2009-09-29
Elizondo David R
VP-Research & Development
Transactions
  • Sale

    Common Stock

    2009-09-30$2.72/sh3,770$10,26057,159.205 total
  • Exercise/Conversion

    Common Stock

    2009-09-29+10,00060,409.179 total
  • Exercise/Conversion

    Restricted Stock Units

    2009-09-2910,00020,000 total
    From: 2007-09-29Exp: 2011-09-29Common Stock (30,000 underlying)
Holdings
  • Restricted Stock Units

    From: 2009-07-30Exp: 2013-07-30Common Stock (40,000 underlying)
    40,000
  • Restricted Stock Units

    From: 2010-03-15Exp: 2014-03-05Common Stock (66,065 underlying)
    66,065
  • Restricted Stock Units

    From: 2008-03-15Exp: 2012-03-15Common Stock (26,511 underlying)
    26,511
  • Restricted Stock Units

    From: 2009-03-15Exp: 2013-03-15Common Stock (70,103 underlying)
    70,103
Footnotes (6)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2009.
  • [F2]Includes shares acquired under the Employee Stock Purchase Plan as of July 31, 2009.
  • [F3]1 unit for 1 share of Common Stock.
  • [F4]Vests in cumulative annual installments of 20% beginning the date shown.
  • [F5]Represents last vesting date.
  • [F6]Vests in 20% annual cumulative installments starting on the date shown; in the second year remaining vesting is subject to acceleration if certain performance criteria are met.

Issuer

ATS MEDICAL INC

CIK 0000824068

Entity typeother

Related Parties

1
  • filerCIK 0001376547

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 5:11 PM ET
Size
14.9 KB